Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04194437 · ClinicalTrials.gov registry record · NA
OCS Liver DCD Trial
A NA study, sponsored by TransMedics.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04194437: Clinical Trial NA study, sponsored by TransMedics.
NCT04194437 is a NA study that was terminated before completion, run by TransMedics. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04194437, a NA study, was terminated before completion, sponsored by TransMedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Evaluate the safety and effectiveness of the OCS Liver System to preserve, optimize the condition, and assess levers from DCD donors.
Primary Outcome
Evaluation of graft survival as defined per UNOS data collection criteria for graft status after liver transplantation
Interventions
- DEVICE OCS Liver System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-07-24 |
| Est. Completion | 2024-12-16 |
| Phase | NA |
Why NCT04194437 stopped before completion
NCT04194437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which OCS Liver System is the first listed.
NCT04194437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04194437 about?
NCT04194437 is a clinical study titled "OCS Liver DCD Trial". Evaluate the safety and effectiveness of the OCS Liver System to preserve, optimize the condition, and assess levers from DCD donors.
What is the current status of trial NCT04194437?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2020-07-24. Estimated completion is 2024-12-16.
What interventions are being tested in trial NCT04194437?
The interventions under investigation include: OCS Liver System (DEVICE).
Who is sponsoring clinical trial NCT04194437?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04194437's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI